✦ LIBER ✦

29 A First-in-Human Phase I Monotherapy Study of RG7212 (R), a Novel Monoclonal Antibody Targeting TWEAK Signaling in Patients with Advanced Solid Tumors

✍ Scribed by Lassen, U.; Schellens, J.H.M.; Siu, L.L.; Jonker, D.J.; Sorensen, M.; Jarutat, T.; Wang, K.; Geho, D.; DeMario, M.; Goss, G.

Book ID: 122694436
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 60 KB
Volume: 48
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(12)71828-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I Safety and Pharmacokinetic Study

Phase I Safety and Pharmacokinetic Study of Bavituximab, a Chimeric Phosphatidylserine-Targeting Monoclonal Antibody, in Patients with Advanced Solid Tumors

✍ Gerber, D. E.; Stopeck, A. T.; Wong, L.; Rosen, L. S.; Thorpe, P. E.; Shan, J. S 📂 Article 📅 2011 🏛 American Association for Cancer Research 🌐 English ⚖ 346 KB

A phase I study of the human monoclonal

A phase I study of the human monoclonal anti-NRP1 antibody MNRP1685A in patients with advanced solid tumors

✍ Weekes, Colin D.; Beeram, Muralidhar; Tolcher, Anthony W.; Papadopoulos, Kyriako 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 387 KB

404 Phase I study of MEDI-575, a fully h

404 Phase I study of MEDI-575, a fully human monoclonal antibody targeting PDGFR-alpha in subjects with advanced solid tumors

✍ R. Lechleider; C. Becerra; M. Liang; R. Narwal; L. Shi; P. Conkling; M. Galsky; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Phase 1 and dose-finding study of patrit

Phase 1 and dose-finding study of patritumab (U3-1287), a human monoclonal antibody targeting HER3, in Japanese patients with advanced solid tumors

✍ Wakui, Hiroshi; Yamamoto, Noboru; Nakamichi, Shinji; Tamura, Yousuke; Nokihara, 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 341 KB

A Phase II and Biomarker Study of Ramuci

A Phase II and Biomarker Study of Ramucirumab, a Human Monoclonal Antibody Targeting the VEGF Receptor-2, as First-Line Monotherapy in Patients with Advanced Hepatocellular Cancer

✍ Zhu, A. X.; Finn, R. S.; Mulcahy, M.; Gurtler, J.; Sun, W.; Schwartz, J. D.; Dal 📂 Article 📅 2013 🏛 American Association for Cancer Research 🌐 English ⚖ 517 KB

A first-in-human, first-in-class, phase

A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors

✍ Shahneen K. Sandhu, Kyri Papadopoulos… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 298 KB